Sarah joins CHASE as Senior Consultant in the Executive Recruitment team with over 20 years’ experience in healthcare/pharmaceutical sales and marketing recruitment in the UK and Australia.
Sarah started her career as a Medical Representative in the UK before transitioning into pharmaceutical sales recruitment. She has spent the last 10 years working in executive sales and marketing recruitment in Australia for roles in multiple sectors including: technology, professional services, mining and healthcare.
She brings a deep knowledge and understanding of how to identify the best talent available across markets through multiple channels, delivering the best possible outcomes for clients and candidates.
Danny Walsh, Recruitment Director at CHASE said:
“We’re delighted that Sarah has joined the Executive Recruitment team at CHASE. Her experience and knowledge within the industry will helps us secure the best senior talent for our clients. Welcome Sarah!"
Explore our latest thinking, event updates and industry insights to stay informed.
The National Cancer Plan for England sets a ten-year strategy to transform outcomes for people diagnosed with cancer by 2035, by reforming the care model.
.jpg)
NHS England has published its MTPF. For pharma, medtech and NHS, it provides financial terms, operational priorities, and strategic direction.
After the breakdown of VPAG negotiations, ABPI & the government agree an extension for VPAG 2026 deadline and an overhaul of NICE’s medicine valuation formula.
.svg)
